GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RushNet Inc (OTCPK:RSHN) » Definitions » Ending Cash Position

RushNet (RushNet) Ending Cash Position : $0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is RushNet Ending Cash Position?

RushNet's Ending Cash Position for the quarter that ended in . 20 was $0.00 Mil.


RushNet Ending Cash Position Historical Data

The historical data trend for RushNet's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RushNet Ending Cash Position Chart

RushNet Annual Data
Trend
Ending Cash Position

RushNet Quarterly Data
Ending Cash Position

RushNet Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

RushNet's Ending Cash Position for the fiscal year that ended in . 20 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=+
=0.00

RushNet's Ending Cash Position for the quarter that ended in . 20 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=+
=0.00


RushNet Ending Cash Position Related Terms

Thank you for viewing the detailed overview of RushNet's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


RushNet (RushNet) Business Description

Traded in Other Exchanges
N/A
Address
8465 Merchants Way, Suite 206, Orange Park, FL, USA, 32222
RushNet Inc through its subsidiary heliosDX, a National Clinical Reference Laboratory offers High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The firm provides physicians individualized customer service, as well as fast and accurate reporting of results. The company invests in its infrastructure with the most efficient scientific proven instruments, and latest software for patient and physician satisfaction. It allows heliosDX to provide physicians fast and accurate reporting meeting. The firm excels in patient and client care through physician designed panels that aid in testing compliance and reporting education.